1. Long non-coding RNA mediated drug resistance in breast cancer
   Deepshikha Singh et al, 2022, Drug Resistance Updates CrossRef
2. Long Noncoding RNAs in Taxane Resistance of Breast Cancer
   Hailong Chen et al, 2023, International Journal of Molecular Sciences CrossRef
3. Dysregulation of the circ_0087502/miR-1179/TGFBR2 pathway supports gemcitabine resistance in pancreatic cancer
   Mingliu Chen et al, 2023, Cancer Biology & Therapy CrossRef
4. A long non-coding RNA with important roles in the carcinogenesis
   Soudeh Ghafouri-Fard et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
5. In Silico and Experimental Analyses of Long Non-coding RNA TMPO-AS1 Expression in Iranian Patients with Gastric Cancer
   Elaheh Mohammadali et al, 2023, International Journal of Cancer Management CrossRef
6. Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
   Peixin Dong et al, 2022, Frontiers in Oncology CrossRef
7. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
   Junjie Gu et al, 2023, Journal of Advanced Research CrossRef
8. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
   Seyedeh Tayebeh Ahmadpour et al, 2023, International Journal of Molecular Sciences CrossRef
9. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer
   Yingmin Jin et al, 2024, BMC Cancer CrossRef
10. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis
    Lili Gao et al, 2021, Cancer Management and Research CrossRef
11. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
    Giasemi C. Eptaminitaki et al, 2022, Drug Resistance Updates CrossRef
12. Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p/Bcl-2 axis
    Jindong Li et al, 2022, European Journal of Histochemistry CrossRef
13. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers
    Shelesh Krishna Saraswat et al, 2024, Pathology - Research and Practice CrossRef
14. Interplay between LncRNAs and microRNAs in Breast Cancer
    Heidi Schwarzenbach et al, 2023, International Journal of Molecular Sciences CrossRef